Detalles de la búsqueda
1.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988749
2.
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 256-266, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476595
3.
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
BMC Cancer
; 21(1): 815, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266398
4.
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.
Breast Cancer Res Treat
; 179(1): 161-171, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605311
5.
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
BMC Cancer
; 18(1): 526, 2018 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728098
6.
Limitations of the PRODIGE 7 trial - Authors' reply.
Lancet Oncol
; 22(5): e179-e180, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932377
7.
Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
Int J Gynecol Cancer
; 26(5): 912-7, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27051055
8.
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
J Genet Couns
; 25(3): 432-42, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26392361
9.
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
BMC Cancer
; 15: 659, 2015 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449988
10.
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473356
11.
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Breast Cancer Res Treat
; 139(3): 789-800, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23780683
12.
Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
Ann Surg
; 254(2): 294-301, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21772129
13.
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy.
Nutrients
; 13(12)2021 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34959982
14.
Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival.
Surgery
; 165(4): 703-711, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449697
15.
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup.
Eur J Cancer
; 122: 91-100, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634648
16.
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer.
Eur J Cancer
; 103: 184-194, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267987
17.
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106).
Eur J Cancer
; 79: 166-175, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28501763
18.
Characterization of an adaptive immune response in microsatellite-instable colorectal cancer.
Oncoimmunology
; 3: e29256, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25101223
19.
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.
Breast Cancer
; 19(1): 16-22, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21088942
20.
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.
Fam Cancer
; 11(1): 77-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22076253
Resultados
1 -
20
de 20
1
Próxima >
>>